Lithium and travel: Goldman Sachs names the ASX growth shares to buy now

These growth shares could be in the buy zone according to Goldman Sachs…

| More on:
A group of young ASX investors sitting around a laptop with an older lady standing behind them explaining how investing works.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Are you looking to add some growth shares to your portfolio for 2023?

If you are, two ASX shares that could be worth considering are listed below. Here's why Goldman Sachs rates them as buys:

Allkem Ltd (ASX: AKE)

The first ASX growth share to consider is Allkem. It is one of the world's largest lithium miners with projects in Argentina, Australia, and North America.

From these projects, Allkem is aiming to grow its production in a way that allows it to maintain a 10% share of global lithium supply over the long term.

Goldman Sachs is bearish on the lithium industry right now due to its belief that lithium prices will tumble in the coming years. However, it is positive on Allkem due to the aforementioned production growth and exposure to several lithium types. This includes moving downstream from spodumene into lithium chemicals, which it sees as a margin accretive opportunity. It commented:

Of our covered Australian lithium companies, Allkem has the best LCE growth outlook with production growing >4x to FY27E with further downstream optionality on carbonate production

Goldman has a buy rating and $15.20 price target on Allkem's shares.

Webjet Limited (ASX: WEB)

Another ASX growth share that Goldman rates as a buy is online travel booking company Webjet.

The broker is a fan of Webjet due to its belief that it has exited the pandemic as a significantly stronger company. It is expecting this to underpin a six-year compound annual growth rate of 15.3% for its earnings. It added:

Our near term earnings changes remain modest given that we already price in a strong recovery for WEB in FY24/25. What these results have given us greater confidence is in the group's longer term outlook for both the Bedbanks and OTA businesses. WEB also continues to report strong cash generation.

Goldman has a conviction buy rating and price target of $6.90 on its shares.

Motley Fool contributor James Mickleboro has positions in Allkem. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

A woman stands at her desk looking a her phone with a panoramic view of the harbour bridge in the windows behind her with work colleagues in the background.
Growth Shares

Analysts say these ASX 200 shares could rise 30% to 40%

Big returns could be on offer with these growing stocks.

Read more »

Four piles of coins, each getting higher, with trees on them.
Growth Shares

2 ASX 200 shares that could be top buys for growth

These two businesses have an exciting future.

Read more »

Man pointing at a blue rising share price graph.
Growth Shares

The 3 biggest ASX multibaggers in 2025

These billion-dollar ASX companies have delivered eye-catching multibagger returns in 2025.

Read more »

A man clenches his fists in excitement as gold coins fall from the sky.
Growth Shares

These world class ASX 200 growth shares could rise 40% to 80%

These high-quality shares are seriously undervalued according to brokers.

Read more »

A male ASX investor sits cross-legged with a laptop computer in his lap with a slightly crazed, happy, excited look on his face while next to him a graphic of a rocket shoots upwards with graphics of stars scattered around it
Healthcare Shares

Up 10x since July, could this hot ASX stock be the next Droneshield?

Investors chase asymmetric upside and 4DMedical is one of the ASX's hottest stocks right now.

Read more »

A bland looking man in a brown suit opens his jacket to reveal a red and gold superhero dollar symbol on his chest.
Growth Shares

3 ASX mid-cap rockets that could become future blue chips

These stocks could be destined for big things in the future according to analysts.

Read more »

People with their hands underneath each other's hands holding a plant.
Growth Shares

2 ASX growth shares I'd buy today for growth and income

Both of these businesses are delivering excellent progress.

Read more »

A man has a surprised and relieved expression on his face.
Growth Shares

These exciting ASX 200 growth shares could rise 60% to 100% in 2026

Analysts believe these shares could be dirt cheap and strong buys right now.

Read more »